Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | -3.26% | 281.89 | 1.4% | $828.75m | |
| AMGN | Amgen, Inc. | -0.74% | 219.67 | 1.3% | $498.30m | |
| CELG | Celgene Corp. | 0.37% | 110.41 | 1.3% | $456.70m | |
| GILD | Gilead Sciences, Inc. | -0.03% | 63.31 | 1.0% | $378.94m | |
| ILMN | Illumina, Inc. | 0.84% | 298.22 | 3.5% | $303.22m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.59% | 207.10 | 1.9% | $299.78m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.03% | 348.30 | 2.6% | $264.62m | |
| EXAS | EXACT Sciences Corp. | -2.08% | 78.25 | 24.0% | $194.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.11% | 107.13 | 2.0% | $183.19m | |
| SGEN | Seattle Genetics, Inc. | 1.42% | 112.21 | 6.1% | $131.55m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.34% | 76.14 | 4.3% | $116.24m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.05% | 101.00 | 14.6% | $115.43m | |
| A | Agilent Technologies, Inc. | 0.13% | 77.15 | 1.6% | $101.09m | |
| MRTX | Mirati Therapeutics, Inc. | -3.45% | 100.73 | 2.3% | $86.61m | |
| NBIX | Neurocrine Biosciences, Inc. | -0.44% | 110.91 | 5.0% | $85.67m |
Company Profile
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.